Original language | English |
---|---|
Pages (from-to) | E844 |
Journal | HemaSphere |
Volume | 7 |
Issue number | 3 |
DOIs |
|
Publication status | Published - 22 Mar 2023 |
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: HemaSphere, Vol. 7, No. 3, 22.03.2023, p. E844.
Research output: Contribution to journal › Comment/Letter to the editor › Academic
TY - JOUR
T1 - Challenges and Opportunities of Precision Medicine in Sickle Cell Disease
T2 - Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet
AU - Collado, Anna
AU - Boaro, Maria Paola
AU - van der Veen, Sigrid
AU - Idrizovic, Amira
AU - Biemond, Bart J.
AU - Beneitez Pastor, David
AU - Ortuño, Ana
AU - Cela, Elena
AU - Ruiz-Llobet, Anna
AU - Bartolucci, Pablo
AU - de Montalembert, Marianne
AU - Castellani, Gastone
AU - Biondi, Riccardo
AU - Manara, Renzo
AU - Sanavia, Tiziana
AU - Fariselli, Piero
AU - Kountouris, Petros
AU - Kleanthous, Marina
AU - Alvarez, Federico
AU - Zazo, Santiago
AU - Colombatti, Raffaella
AU - van Beers, Eduard J.
AU - Mañú-Pereira, María Del Mar
N1 - Funding Information: GA 101017549 – GENOMED4ALL - H2020-SC1-FA-DTS-2020-1. ‘Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases’. Instituto de Salud Carlos III through the project ‘PI20/01454: ENABLING PERSONALIZED MEDICINE OF SICKLE CELL DISEASE PATIENTS BASED ON INTEGRATIVE DIAGNOSIS OF NEW GENERATION METHODOLOGIES’ (Co-funded by European Regional Development Fund/European Social Fund; ‘A way to make Europe’/’Investing in your future”). GA 101085717 - ERN-EuroBloodNet – EU4H-2022-ERN-IBA-01 - European Reference Network on Rare hematological diseases – ERN-EuroBloodNet.
PY - 2023/3/22
Y1 - 2023/3/22
UR - http://www.scopus.com/inward/record.url?scp=85149211000&partnerID=8YFLogxK
U2 - https://doi.org/10.1097/HS9.0000000000000844
DO - https://doi.org/10.1097/HS9.0000000000000844
M3 - Comment/Letter to the editor
C2 - 36844183
SN - 2572-9241
VL - 7
SP - E844
JO - HemaSphere
JF - HemaSphere
IS - 3
ER -